ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2015 ACR/ARHP Annual Meeting

November 6-11, 2015 in San Francisco, CA

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
  • Abstract Number: 1937
    Dalazatide (ShK-186), a First-in-Class Blocker of Kv1.3 Potassium Channel on Effector Memory T Cells: Safety, Tolerability and Proof of Concept of Immunomodulation in Patients with Active Plaque Psoriasis
  • Abstract Number: 3031
    Dalazatide (ShK-186), a Kv1.3 Channel Inhibitor That Targets Effector Memory T Cells: Ex Vivo Studies in Pediatric Systemic Lupus Erythematosus
  • Abstract Number: 1944
    Dalazatide Modulates CD4+ Effector Memory T-Cell Activity of Patients with Granulomatosis with Polyangiitis in Vitro
  • Abstract Number: 731
    Damage and Mortality in SLE: Cluster Analysis of Patients from SLE Registry from the Spanish Society for Rheumatology (RELESSER)
  • Abstract Number: 2156
    Damage Assessment in Giant Cell Arteritis
  • Abstract Number: 3068
    Damage Assessment in Takayasu’s Arteritis
  • Abstract Number: 876
    Damage Develops Early and Is Common in Children with Chronic Systemic Vasculitis
  • Abstract Number: 2623
    DAS28-ESR and DAS28-CRP Are Not Exchangeable in Daily Clinical Practice: Data from a Large Outpatient Cohort
  • Abstract Number: 70
    Data from Brazilian Fibromyalgia Patients Registry (EPIFIBRO) in 2014
  • Abstract Number: 2085
    DC-STAMP Regulates Osteoclastogenesis through the Ca2+ /NFATc1 Axis
  • Abstract Number: 2067
    De-Convolution of Whole Blood Transcriptomic Data from a Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept in Systemic Lupus Erythematosus
  • Abstract Number: 1404
    Death and Infection Rates Appear Reduced in a Modern Cohort of ICU Patients with Rheumatic Disease
  • Abstract Number: 1254
    Deciphering the Immunome of Clinically Effective Immune Tolerization in Rheumatoid Arthritis
  • Abstract Number: 2257
    Decline of Lung Function Is Associated with the Presence of Rheumatoid Factor in Korean Health Screening Subjects without Clinically Apparent Lung Diseases
  • Abstract Number: 2252
    Declining Post-Arthroplasty Mortality after Total Knee Arthroplasty in the U.S.: A Time-Trends Study
  • Abstract Number: 3237
    Decreased Cardiovascular Mortality in Patients with Incident Rheumatoid Arthritis (RA) in Recent Years: Dawn of a New Era in Cardiovascular Disease in RA?
  • Abstract Number: 732
    Decreased Disease Activity and Corticosteroid Usage and Improved Quality of Life during Belimumab Treatment in Patients with Systemic Lupus Erythematosus – a Prospective Real-Life Observational Study
  • Abstract Number: 1116
    Decreased Expression of Negative Regulators of Toll-like Receptor Signaling and Increased TLR7 Responsiveness in Expanded IgD- CD27- B Cells from Systemic Lupus Erythematosus Patients
  • Abstract Number: 3023
    Decreased Intracellular Calcium Flux in Follicular Helper T Cells after T Cell Receptor Stimulation
  • Abstract Number: 2643
    Decreased Pain Level with Aging Leads to Underestimation of Disease Activity in Rheumatoid Arthritis
  • Abstract Number: 2529
    Decreased Programmed Death Ligand-1 (PD-L1) in Systemic Lupus Erythematosus (SLE) Placenta
  • Abstract Number: 502
    Decreased Vaccine Responses in Rheumatoid Arthritis Patients Receiving Anti-TNF Treatment and Relationship to B Cell Subsets
  • Abstract Number: 1875
    Deep Vein Thrombosis and Pulmonary Embolism in Systemic Sclerois
  • Abstract Number: 2087
    Defective Circadian Control in Mesenchymal Cells Reduces Adult Bone Mass
  • Abstract Number: 1887
    Deficiency in Micronutrients Is a Frequent Burden in Patients with Systemic Sclerosis
  • Abstract Number: 3092
    Deficiency of Adenosine Deaminase Type II – Expanding the Clinical Spectrum
  • Abstract Number: 2014
    Deficiency of IL-27 Exacerbate Sjögren’s Syndrome through Inhibiting Differentiation of Type 1 Regulatory T Cells
  • Abstract Number: 1146
    Deficiency of TLR2 and TLR4 Impairs Autophagic Flux in Chondrocytes
  • Abstract Number: 1309
    Defining an Acceptable Level of MRI Inflammation in Rheumatoid Arthritis
  • Abstract Number: 915
    Defining Pain for Fibromyalgia Criteria: Multi-Site or Widespread?  an Analysis of Data from Four UK Population-Based Studies
  • Abstract Number: 587
    Defining the Conditions Under Which Long-Term Glucocorticoid Treatment Has a Good Benefit-Risk Ratio
  • Abstract Number: 1748
    Degenerative Changes at the Lumbar Spine in Patients with Axial Spondyloarthritis and Non-Specific Mechanical Low Back Pain: A Magnetic Resonance Imaging Study
  • Abstract Number: 933
    DEK-Targeting DNA Aptamers As Novel Therapeutics for Inflammatory Arthritis
  • Abstract Number: 132
    Delivering a One-Stop, Integrated, Patient-Centred Service for Patients with Rheumatic Diseases. the Finnish Approach
  • Abstract Number: 12
    Delta-like 1 Enhances the Production of Pro-Inflammatory Mediators By Fibroblast-like Synoviocytes
  • Abstract Number: 2084
    Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Modulates Bone Resorption in Inflammatory Arthritis and Fracture Repair
  • Abstract Number: 384
    Dental Treatments, Tooth Extraction, and Osteonecrosis at Jaw in Japanese Patients with Rheumatoid Arthritis; Results from the IORRA Cohort Study
  • Abstract Number: 747
    Depletion of Serum Soluble CD40L Characterizes the Association Between Systemic Lupus Erythematosus  and Thrombotic Thrombocytopenic Purpura: Longitudinal, Single-Center Study
  • Abstract Number: 2512
    Depot Medroxyprogesterone Acetate Birth Control May Suppress Toll-like Receptor 7-Induced Interferon-Alpha Production By Plasmacytoid Dendritic Cells in Women
  • Abstract Number: 1811
    Depression and Progression of Subclinical Cardiovascular Disease in Systemic Lupus Erythematosus
  • Abstract Number: 395
    Depression Risk Among Adults with Childhood- and Adult-Onset Systemic Lupus Erythematosus: 11 Years of Follow-up
  • Abstract Number: 2337
    Depression, Bad Sleep Quality, and Functional Deficit Are Independently Associated with Persistent Fatigue in Arthritic Patients with Low Disease Activity Under Biological Dmards
  • Abstract Number: 1967
    Deregulation of Interleukin-22 Pathway in Giant Cell Arteritis
  • Abstract Number: 2332
    Deriving ‘population References’ of Health Utilities for Patients with Spondyloarthritis Based on the ASAS Health Index
  • Abstract Number: 1587
    Deriving a Comorbidity Index Form the Meddra Classification: Performance of  Rheumatic Disease Comorbidity Index, Charlson-Deyo Index and Functional Comorbidity Index Among Patients with RA in NOR-DMARD Cohort
  • Abstract Number: 2369
    Dermatomyositis Associated with Anti-Melanoma Differentiation-Associated Gene 5 Antibodies: A Longitudinal Analysis
  • Abstract Number: 2329
    Describe Treatments As ‘new’ or ‘old’ at Your Peril: Influences on Patient Decision Making
  • Abstract Number: 420
    Description of the Juvenile Localized Scleroderma Subgroup of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry
  • Abstract Number: 1442
    Descriptive Characteristics of Patients Prescribed Opioids for the Treatment of Chronic Pain
  • Abstract Number: 1198
    Design and Implementation of a Patient-Centered Navigator Program to Improve Adherence to Disease-Modifying Antirheumatic Drugs
  • Abstract Number: 1315
    Detecting Subtle Changes in Bone Structure Following Three-Month Anti-TNF Theraphy Using High-Resolution Peripheral Quantitative Computed Tomography
  • Abstract Number: 1358
    Detection of a Unique Viral Infection in Salivary Glands of Sjögren’s Syndrome Patients and Viral-Mediated Recapitulation of Disease in Vivo
  • Abstract Number: 2397
    Detection of Changes in the Serum and Synovial Fluid Levels of Resistin during Flare Ups and Remissions in Primary Knee Osteoarthritis
  • Abstract Number: 187
    Detection of Power Doppler Ultrasound Signals in Rheumatic Diseases Using Superb Microvascular Imaging (SMI): Comparison with Conventional Power Doppler Ultrasound
  • Abstract Number: 1525
    Detection of Previous Tuberculosis Infections in Japanese Rheumatoid Arthritis Patients: Comparison of Two Interferon-G Releasing Assays and the Impact of CD4-Positive Lymphocytes
  • Abstract Number: 2924
    Determinants of Damage in an SLE Cohort: Real World Data
  • Abstract Number: 2672
    Determinants of Patient- Physician Discordance in Assessment of Global Disease Activity in Latinos with Rheumatoid Arthritis in the United States
  • Abstract Number: 363
    Determination of the Osteoporotic Vertebral Fractures By a New Quantitative Approach: Intervertebral Volume Index
  • Abstract Number: 2501
    Determining the Rate of Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis at Federally Qualified Outpatient Continuity Clinic – a Performance Improvement Project
  • Abstract Number: 1190
    Developing an Introductory Musculoskeletal Ultrasound Curriculum for Rheumatology Fellows
  • Abstract Number: 1917
    Developing and Validating a Serum Biomarker for the Extent of Skin Disease in Patients with Diffuse Cutaneous Systemic Sclerosis
  • Abstract Number: 419
    Development and Preliminary Validation of a New Composite Disease Activity Measure for Juvenile Dermatomyositis
  • Abstract Number: 2445
    Development and Usability Testing of an Ipad-Based Psycho-Educational Game for Children with Juvenile Idiopathic Arthritis and Their Parents
  • Abstract Number: 2679
    Development and Validation of a HAQ-Derived Tool to Detect Muscle Mass Deficits in Rheumatoid Arthritis
  • Abstract Number: 2632
    Development and Validation of a Questionnaire Assessing the Fears and Beliefs of Patients Suffering from Chronic Rheumatic Diseases
  • Abstract Number: 3093
    Development and Validation of Diagnostic Criteria for Cryopyrin Associated Periodic Syndromes
  • Abstract Number: 1484
    Development and Validation of Juvenile Autoinflammatory Disease Multidimensional Assessment Report (JAIMAR)
  • Abstract Number: 828
    Development of a Disease Damage Index in Systemic Sclerosis Using Consensus and Data Driven Methods
  • Abstract Number: 2027
    Development of a Dual Energy Computed Tomography Scoring System for Measurement of Urate Deposition in Gout
  • Abstract Number: 415
    Development of a Juvenile Systemic Sclerosis Response Index (JSSRI)
  • Abstract Number: 1712
    Development of a Novel SI Joint CT Score for Diagnosis of Axial Spondylitis
  • Abstract Number: 708
    Development of an Activity Disease Score in Patients with Uveitis
  • Abstract Number: 870
    Development of an Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Patient-Reported Outcome Measure: Identification of Salient Themes and Candidate Questionnaire Item Development
  • Abstract Number: 943
    Development of an Internationally Agreed Minimal Dataset for Juvenile Dermatomyositis (JDM) for Clinical and Research Use
  • Abstract Number: 926
    Development of an Ultrasound Joint Inflammation Score for Rheumatoid Arthritis through a Data-Driven Approach
  • Abstract Number: 2076
    Development of Lupus Nephritis: Preclinical Evaluation of Patients Who Subsequently Develop Systemic Lupus Erythematosus Demonstrate Elevation of Select Soluble Mediators Prior to and at Disease Classification in Patients with Nephritis
  • Abstract Number: 29
    Development of Multimorbidity in Patients with Newly Diagnosed Rheumatoid Arthritis – a Population-Based Study
  • Abstract Number: 1635
    Development of New Bioassay System Measuring Inhibitory Strength of IL-6/STAT3 Signal Under Tocilizumab Treatment in Rheumatoid Arthritis Patients
  • Abstract Number: 999
    Development of Quality Indicators for Hip and Knee Arthroplasty Rehabilitation
  • Abstract Number: 1402
    Development of Systemic Juvenile Idiopathic Arthritis Manifestations Following Remission of Hemophagocytic Lymphohistiocytosis
  • Abstract Number: 1904
    Development of the Mawdsley Calcinosis Questionnaire (MCQ) Version 1 – a Patient-Reported Outcome Measure (PROM) for Systemic Sclerosis Related Calcinosis (SSc-Ca)
  • Abstract Number: 3179
    Diagnosing Childhood Small Vessel CNS Vasculitis
  • Abstract Number: 1596
    Diagnosis of Carotid Plaque By 4 Cardiovascular Risk Scores in Rheumatoid Arthritis
  • Abstract Number: 2952
    Diagnosis of Primary Neuropsychiatric Systemic Lupus Erythematosus: Attribution Models Versus Physician Judgment
  • Abstract Number: 2908
    Diagnostic and Screening Accuracy of Spot Urinary Protein-Creatinine Ratio Compared to Protein Content in a 24 Hour-Urine Collection in Systemic Lupus Erythematosus: Systematic Review and Meta-Analysis
  • Abstract Number: 1393
    Diagnostic Categorization of Ocular Sarcoidosis Based on the International Criteria Proposed By the First International Workshop on Ocular Sarcoidosis. a Case Series of 11 Spanish Patients
  • Abstract Number: 493
    Diagnostic Delay in Early Arthritis: Ten Years-Experience of a Single Center
  • Abstract Number: 1878
    Diagnostic Performance of the 2013 ACR/EULAR Classification Criteria for Systemic Sclerosis: Results from a Brazilian Validation Cohort
  • Abstract Number: 2653
    Diagnostic Value of the Prednisolone Test in Patients with Possible Rheumatoid Arthritis
  • Abstract Number: 1958
    Diagnostic Value of Ultrasonography-Derived Signs in Giant Cell Arteritis: Literature Review and Meta-Analysis
  • Abstract Number: 3169
    Diagnostic Value of Ultrasound for the Diagnosis of Gout in a Prospective Cross-Sectional Study
  • Abstract Number: 2929
    Diet and Glucocorticoid Treatment in Patients with SLE
  • Abstract Number: 218
    Diet-Wide Association Study of Serum Urate Levels in 13,782 Individuals of European Ancestry
  • Abstract Number: 1783
    Dietary Fish Oil Supplementation Raises Serum Essential Fatty Acid Concentrations in Patients with Systemic Lupus Erythematosus and Correlates with Improvements in Inflammation and Pain
  • Abstract Number: 3247
    Dietary Intake of Omega-3 Fatty Acids and Vitamin C and D Associate with Decreased Pain, Independent of Inflammation, in MTX Treated Early RA Patients
  • Abstract Number: 2095
    Dietary Patterns (DASH, Prudent, Western Diets) and the Risk of Gout in US Women – the Nurses Health Study
  • Abstract Number: 875
    Differences in Early Damage Patterns in Various Forms of Primary Systemic Vasculitis
  • Abstract Number: 209
    Different Autoimmune Rheumatic Diease IgG Have Differential Effects upon Neutrophil Binding, Activation and Neutrophil Extracellular Trap Formation
  • Abstract Number: 296
    Different Patterns of Involvement of Thigh Muscles in Dermatomyositis and Polymyositis Using Fat-Suppressed Magnetic Resonance Sequences
  • Abstract Number: 2202
    Different Patterns of Positivity for IgG Anti-Cardiolipin, Anti-Beta-2-Glycoprotein I and Anti-Domain I Antibodies within the First Year of Disease in 501 Patients with SLE  – Associations  with Different Clinical Outcomes
  • Abstract Number: 3258
    Different Perception of Disease Activity in Multimorbid Rheumatoid Arthritis Patients
  • Abstract Number: 2317
    Different Rheumatoid Arthritis Disease Activity Measures Often Provide Discordant Results in Clinical Practice Populations
  • Abstract Number: 2646
    Different Wording of the Patient Global Assessment Scale Leads to Different Rating of Disease Activity
  • Abstract Number: 1260
    Differential DNA Methylation and Reduced Expression of Transcription Factors in Human OA Cartilage
  • Abstract Number: 1245
    Differential DNA Methylation Associated with Lupus Nephritis Shows Enrichment in Genes Involved in Regulation of TH2 Differentiation and Renal Development
  • Abstract Number: 3099
    Differential Effects of IL-6 Blockade Tocilizumab and TNF Inhibitors on the Reduced Angiogenesis and Lining Layer Degeneration in Synovial Tissues from Patients with Rheumatoid Arthritis
  • Abstract Number: 1391
    Differential Expression of Interferon Gamma in Exudate from Hidradenitis Suppurativa Lesions Compared to Chronic Wounds
  • Abstract Number: 1249
    Differential Expression of SLE Susceptibility Genes By Interferon-Alpha and the HLA-DRB1*03:01 Haplotype in Ex Vivo B Cells
  • Abstract Number: 1139
    Differential Inflammatory Profile in Experimental Models of Arthritis
  • Abstract Number: 1920
    Differential Production of Th17-Related Cytokines By Toll like Receptor (TLR)-Ligands-Stimulated Monocyte-Derived Dendritic Cells (Mo-DCs) from Systemic Sclerosis (SSc) Patients; Relevance of IL-22 and IL-33 According to Disease Subtype and Stage
  • Abstract Number: 2949
    Differential Serum Cytokine Profile in Patients with Systemic Lupus Erythematosus and Posterior Reversible Encephalopathy Syndrome: A Single-Center Study
  • Abstract Number: 1010
    Differing Perspectives Between Doctor, Nurse and Patient Views on Professionalism and Empathy: An Inter-Professional 360-Degree Rheumatology Objective Structured Clinical Examination
  • Abstract Number: 2945
    Diffuse Alveolar Hemorrhage in SLE:  Risk Factors, Response to Therapy, and Survival
  • Abstract Number: 879
    Diffuse Alveolar Hemorrhage Secondary to ANCA-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes
  • Abstract Number: 1728
    Diffusion Weighted Imaging Is a Sensitive and Specific MRI Protocol for the Diagnosis and Assessment of Disease Severity in Ankylosing Spondylitis
  • Abstract Number: 359
    Diminished Health-Related Quality of Life As Measured By the Short Form-10 in Children with Hypophosphatasia
  • Abstract Number: 2297
    Dinamyx Neuromodulation in Fibromyalgia
  • Abstract Number: 789
    Direct Coombs Positivity in SLE
  • Abstract Number: 65
    Disability in the Rheumatic Diseases
  • Abstract Number: 2863
    Discontinuation of Anti-TNF Therapy in Patients with Axial Spondyloarthritis. a Systematic Literature Review
  • Abstract Number: 2007
    Discovery of an Intra-Articular Injection Small Molecule Inhibitor of the Wnt Pathway (SM04690) As a Potential Disease Modifying Treatment for Knee Osteoarthritis
  • Abstract Number: 1248
    Discovery of Novel Serum Biomarkers for Osteoarthritis Using Affinity Proteomics
  • Abstract Number: 1671
    Discovery of PRN1008, a Novel, Reversible Covalent BTK Inhibitor in Clinical Development for Rheumatoid Arthritis
  • Abstract Number: 595
    Discovery of Serum Protein Biomarkers of Response to Adalimumab in Rheumatoid Arthritis and Their Relationship to Biomarkers of Response to Infliximab
  • Abstract Number: 2689
    Discrepancies Between Patients and Physicians in Their Perceptions of Rheumatoid Arthritis Disease Activity Are Multifactorial in Early Rheumatoid Arthritis
  • Abstract Number: 1227
    Discrepancies Between Registered and Published Primary Outcomes in Randomized Controlled Trials of Rheumatoid Arthritis
  • Abstract Number: 671
    Discrepancy Between Patients and Physicians Acceptable Symptomatic States in Axial Spondyloarthritis: Findings from the RAPID-AxSpA Study
  • Abstract Number: 862
    Discriminative Performance of Nasal Endoscopic Findings and History Items in Patients with Granulomatosis with Polyangiitis
  • Abstract Number: 400
    Disease Activity and Health Care Utilization Among Young Adults with Childhood-Onset Lupus Transitioning to Adult Care: Data from the Pediatric Lupus Outcomes Study
  • Abstract Number: 2839
    Disease Activity and Safety during Long-Term (104-Week) Treatment with Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension
  • Abstract Number: 2532
    Disease Activity in Women with Systemic Lupus Erythematosus during Pregnancy and the First Year Post Partum
  • Abstract Number: 666
    Disease Activity Indices and Body Mass Index: Cross-Sectional Analysis of a Large Psoriatic Arthritis Cohort
  • Abstract Number: 130
    Disease Activity Patterns in Incident Onset Rheumatoid Arthritis Patients in the First 3-Years of Follow up
  • Abstract Number: 2927
    Disease Activity Patterns over Time in Patients with SLE – a Retrospective Descriptive Analysis of the Hopkins Lupus Cohort
  • Abstract Number: 2626
    Disease Activity Predicts ABCB1 and ABCG2 Drug-Efflux Transporters Function in Rheumatoid Arthritis (RA) Patients
  • Abstract Number: 409
    Disease Activity, Disease Damage and Predictive Factors in Juvenile Onset Mixed Connective Tissue Disease – a Norwegian Nationwide Study
  • Abstract Number: 456
    Disease and Treatment Characteristics That Might Influence Long-Term Retention with Biologics in the Real-World Clinical Setting: Experience from the Rhumadata Clinical Database and Registry 
  • Abstract Number: 2935
    Disease Evolution in Late Onset and Early Onset Systemic Lupus Erythematosus (SLE)
  • Abstract Number: 470
    Disease Outcome in Patients Fulfilling the 2010 Classification Criteria for Rheumatoid Arthritis: The Impact of the Different Criteria Components
  • Abstract Number: 734
    Disease Patterns, Flare Incidence and Organ Damage Among Filipino Patients with Systemic Lupus Erythematosus: a One-Year Observational Study
  • Abstract Number: 1778
    Disease Progression Is Altered By Moderate Exercise and Social Stress in a Murine Model of Lupus Nephritis
  • Abstract Number: 1677
    Disease-Regulated Expression of Anti-Inflammatory Interleukin-10 for the Treatment of Rheumatoid Arthritis
  • Abstract Number: 17
    Disentangling the Role of Hypoxia-Inducible Factor 1 and 2 in the Adaption Process of Human Microvascular Endothelial Cells to Pathophysiological Hypoxia
  • Abstract Number: 2011
    Disruption of the Molecular Clock in Mesenchymal Cells Causes an Osteoarthritis-like Disease in Mice
  • Abstract Number: 1024
    Disruptions in Folate Homeostasis May Lead to Increased Risk for Methotrexate Intolerance in Juvenile Idiopathic Arthritis
  • Abstract Number: 1968
    Distinct Distribution Patterns of Large Vessel Vasculitis Assessed with 18f-FDG PET/CT: Evidence from Principal Component and Cluster Analyses
  • Abstract Number: 906
    Distinct Expression of IL-36α, β, γ and Their Antagonists IL-36Ra and IL-38 in Psoriasis, Rheumatoid Arthritis and Crohn’s Disease
  • Abstract Number: 2172
    Distribution of Clinical Osteoarthritis and Associations to Health-Related Quality of Life in a Population-Based Osteoarthritis Cohort
  • Abstract Number: 929
    Diurnal Variation of Power Doppler in Metacarpophalangeal Joints of Patients with Rheumatoid Arthritis
  • Abstract Number: 797
    Divergent Phenotypic Patterns Between Systemic Lupus Erythematosus and Healthy Anti-Nuclear Antibody Positive Individuals Reveal Distinct Differences in B Cell and Myeloid Populations Among Ethnicities
  • Abstract Number: 1160
    DNA Hydroxylmethylation Regulates Pro-Inflammatory Cytokine Expression in Macrophages
  • Abstract Number: 1250
    DNA Methylation and Its Relation to Immunological Phenotypes in Peripheral Blood: A Study of Anti-CCP Antibody Positivity from a Population-Based Pool
  • Abstract Number: 1610
    DNA Methylation Changes Observed in Rheumatoid Arthritis Joint Tissue Are Detectable in CD4+ Naive T Cells from Peripheral Blood
  • Abstract Number: 2017
    DNA Methylation Governs the Ability of Apoptotic Cells to Suppress Inflammatory Arthritis Via Reciprocal Regulation of IL-6 and TGF-Beta
  • Abstract Number: 1074
    DNA Methylation Patterns in Naïve CD4+ T Cells Identify Epigenetic Susceptibility Loci for Malar Rash and Discoid Rash in Systemic Lupus Erythematosus
  • Abstract Number: 1620
    DNA Methylation Profiling of Rheumatoid Arthritis Peripheral Blood Identifies Hypermethylation of TRIM69 Promoter Region in CD4+ T Cells Associated with Disease Activity
  • Abstract Number: 2788
    DNA Microarray Analysis of Labial Salivary Glands in Patients with Sjögren’s Syndrome: Comparison with IgG4-Related Disease
  • Abstract Number: 2002
    Dnase Treatment Protects Against DVT Formation in a Mouse Model of Antiphospholipid Syndrome
  • Abstract Number: 3241
    Do Boosters Support Long-Term Physical Activity Maintenance after an Intervention? a Systematic Review
  • Abstract Number: 3165
    Do Omega-3 Fatty Acids Reduce Risk of Recurrent Gout Attacks?
  • Abstract Number: 1974
    Do Patients with Giant Cell Arteritis Meet the 2011 United Kingdom Department of Health Guidance on Physical Activity?
  • Abstract Number: 2918
    Do Patients with Lupus Nephritis Who Achieve Complete Proteinuria Recovery at 2 Years Have Better Long Term Outcomes Compared to Patients with Partial Proteinuria Recovery?
  • Abstract Number: 1632
    Do RA Susceptibility Loci Predict Response to Methotrexate As First DMARD in Early RA?
  • Abstract Number: 2327
    Documentation of Clinical Improvement in Patient with Polymyalgia Rheumatica According to MDHAQ/RAPID3 (Multidimensional Health Assessment Questionnaire/Routine Assessment of Patient Index Data): Longitudinal Analysis from Routine Care
  • Abstract Number: 2491
    Documentation of Disease Activity Score As Part of a Treat to Target Strategy in Rheumatoid Arthritis
  • Abstract Number: 2627
    Does 14-3-3 ETA Protein Offer Any Additional Diagnostic Value in Rheumatoid Arthritis?
  • Abstract Number: 1086
    Does Adding Azathioprine to Glucocorticoid Induction Increase the Remission Rate and Prevent Relapses in Patients with Systemic Necrotizing Vasculitides without Poor-Prognosis Factors? a Multicenter, Double-Blind Randomized Controlled Trial
  • Abstract Number: 2478
    Does Affect Predict Willingness to Take Medication?
  • Abstract Number: 686
    Does an Educational Leaflet Improve Attendance for Screening for Psoriatic Arthritis?
  • Abstract Number: 2449
    Does Antinuclear Antibodies Predict Remission in JIA ?
  • Abstract Number: 2271
    Does Arthritis in the Young Adult Life Phase Impact Involvement in Transitional Social Roles?
  • Abstract Number: 1307
    Does Computerized Segmentation of Early Erosions on Magnetic Resonance Imaging Predict Functional Ability in Rheumatoid Arthritis?
  • Abstract Number: 2077
    Does Dysbiosis within the Intestinal Microbiome Contribute to SLE Pathogenesis?
  • Abstract Number: 3246
    Does Loss of a Community Walking Speed Lead to More Symptoms of Depression in Knee OA? a Trajectory Analysis from the Osteoarthritis Initiative
  • Abstract Number: 1791
    Does Renin-Angiotensin System Blockade Protect Lupus Nephritis Patients from Atherosclerotic Cardiovascular Events?  a Case-Control Study
  • Abstract Number: 851
    Does the Clinical Context Improve the Reliability of Rheumatologists Grading Digital Ulcers in Systemic Sclerosis?
  • Abstract Number: 2518
    Does the Cytokine Pattern, Including the IL23 – IL17 Immune Axis, Change in Pregnant Women with Psoriatic Arthritis?
  • Abstract Number: 659
    Does the Inclusion of Extra-Articular Manifestations Improve Validity of the Self-Administered Comorbidity Questionnaire Modified for Spondyloarthritis (SpA-SCQ)? Results from ASAS-Comospa
  • Abstract Number: 1678
    Does the Level of Disease Control Achieved with Biologics Influence Overall Costs for Health Care and Work Loss in RA?
  • Abstract Number: 42
    Does the Risk of Mortality in Patients with RA Change over Time or Disease Duration?
  • Abstract Number: 1995
    Does the Risk of Serious Infections Among Elderly RA Patients Differ By Age of Disease Onset?
  • Abstract Number: 106
    Does the Timing of Phenotype Assessment Influence Association Results in Pharmacogenetics Studies of Anti-TNF Response in Rheumatoid Arthritis?
  • Abstract Number: 2074
    Dominant Chilblain Lupus Due to an Activating Mutation of Sting – Suppression of Constitutive Type I Interferon Activation By JAK Inhibition
  • Abstract Number: 758
    Dominican Patients with Systemic Lupus Erythematosus Residing in New York City Have a Higher SLICC/ACR Damage Index Than Those in the Dominican Republic
  • Abstract Number: 2206
    Dopamine Pathway and Bone Metabolism in Arthritis
  • Abstract Number: 3094
    Dose Adjustment of Anakinra (Kineret®) Based on Clinical Response in Patients with Severe Cryopyrin-Associated Periodic Syndromes
  • Abstract Number: 2149
    Dose Reduction Compared with Standard Dosing for Maintenance of Remission in Patients with Spondyloarthropathies and Clinical Remission with Anti-TNF: A Randomised Real-Life Trial
  • Abstract Number: 49
    Dose Relationship Between Oral Glucocorticoids and TNF Inhibitors and the Risk of Hospitalized Infectious Events Among Patients with Rheumatoid Arthritis
  • Abstract Number: 570
    Dose Selection of Namilumab, an Anti-GM-CSF Monoclonal Antibody: An Integrated Pharmacokinetic and Pharmacodynamic Approach for Phase II Studies in Patients with Rheumatoid Arthritis
  • Abstract Number: 957
    Double Blind Placebo Controlled Randomized Trial of Probiotics in Enthesitis-Related-Arthritis Category of JIA: Effect on Clinical and Immunological Parameters
  • Abstract Number: 1127
    Downregulation of nuclear Factor-Erythroid 2-Related Factor (Nrf2)/Heme Oxygenase-1 Axis in Diabetic Cartilage: Towards a Better Phenotyping of diabetes-Related Osteoarthritis
  • Abstract Number: 1987
    Dramatic Efficacy of Tocilizumab As First Line Therapy in Patients with Recent Polymyalgia Rheumatica (PMR): Results of the First Longitudinal Prospective Study
  • Abstract Number: 2777
    Drug Retention Rates of Biologic Monotherapies for Patients with Rheumatoid Arthritis Receiving TNF Inhibiting Fusion Protein Agent and Antibody Agent; From Multicenter Registry in Japan
  • Abstract Number: 2140
    Drug Specific Risk and Associated Factors for Vasculitis-like Events in Patients Exposed to Tumour Necrosis Factor-α Inhibitor Therapy: Results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
  • Abstract Number: 2105
    Drug Survival and Cost Effectiveness in Patients on Reduced Dose Anti-TNF: Results of a 4 Year Prospective Observational Study
  • Abstract Number: 443
    Drug Survival and Reasons for Discontinuation of Biological Disease Modifying Antirheumatic Drug in Thai Patients with Rheumatoid Arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization (RDPA) Register
  • Abstract Number: 489
    Drug Survival and Toxicity of Methotrexate Monotherapy in Daily Clinical Practice.  Results from an Early Arthritis Clinic
  • Abstract Number: 1267
    Drug Survival of Second Biologic DMARD Therapy in Patients with Rheumatoid Arthritis: Comparison of a Second Anti-TNF with a Second Non-Anti-TNF after Discontinuation of a First Anti-TNF
  • Abstract Number: 1288
    Dual Care Utilization in Patients Enrolled in the Veterans Affairs Rheumatoid Arthritis Registry
  • Abstract Number: 318
    Dual Variable Domain-Immunoglobulin (Dvd-Ig™) Abt-981 Simultaneously and Dose-Dependently Inhibits Interleukin-1 Αlpha and -1 Βeta in Subjects with Knee Osteoarthritis
  • Abstract Number: 434
    Duration of Remission By Currently Available Criteria Can Predict Physical Functioning, but Not Radiological Progression in Early Rheumatoid Arthritis Patients
  • Abstract Number: 1163
    Dynamic Regulation of Enhancers and Super-Enhancers in Rheumatoid Arthritis Synovial Finroblasts
  • Abstract Number: 1563
    Dyslipidemia and Hyperglycemia, Two Cardiometabolic Parameters, Independently Predict Poor Outcome in Early Rheumatoid Arthritis: Results from Espoir Cohort
  • Abstract Number: 2716
    Dysregulated Osteoclastogenesis Is Related to Natural Killer T Cell Dysfunction in Rheumatoid Arthritis
Jump to:  View All • a b c [d] e f g h i j k l m n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Chicago, IL

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.